Platelet-dependent Thrombosis: a Placebo-controlled Trial of Antiplatelet Therapy (Clopidogrel)
Status:
Completed
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
Patients with diabetes are more likely to develop furring of their coronary arteries and
present with angina and heart attacks. Furthermore, after such an event, they have poorer
outcomes (higher rates of death) and survivors are more likely to have recurring symptoms.
Using a novel "clotting chamber" the investigators have shown that patients with diabetes are
more likely to develop blood clots. This study will look at the role of different blood
thinning medications in patients with diabetes. If successful, the investigators will provide
evidence to conduct large clinical studies to look at the role of additional blood thinning
medication in reducing heart attacks and strokes in patients with diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Newcastle-upon-Tyne Hospitals NHS Trust
Collaborators:
British Heart Foundation University of Newcastle Upon-Tyne